NCT00383435 - Effects of Mometasone Furoate/Formoterol Combination Versus Formoterol and Mometasone Furoate Alone in COPD (Study P04229AM4)(COMPLETED) | Biotech Hunter

Enrollment

1,055

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Interventions

DRUG

Mometasone furoate/formoterol (MF/F) combination

MF/F 400/10 mcg via a metered dose inhaler (MDI) twice daily for 52 weeks

DRUG

Mometasone furoate/formoterol (MF/F) combination

MF/F 200/10 mcg via a metered dose inhaler (MDI) twice daily for 52 weeks

DRUG

Mometasone furoate MDI (MF MDI)

MF 400 mcg via metered dose inhaler twice daily for 52 weeks

DRUG

Formoterol MDI

Formoterol 10 mcg via metered dose inhaler twice a day for 52 weeks

DRUG

Placebo

Placebo MDI twice a day for 26 weeks